Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #187961 on Biotech Values
mcbio
02/28/15 1:00 AM
#187974 RE: biomaven0 #187961
>> RTH258 Clearly a long-term threat to Eyelea here. Better efficacy (if only marginally) plus less frequent administration makes for a clearly superior drug. I sold my REGN based on this news. Might be a year or more early, but who knows.